Vifor Pharma AG (GNHAF)

Add to Watchlists
Create an Alert
151.23 +0.00  +0.00% OTC Markets Aug 16, 20:00 Delayed 15m USD

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.viforpharma.com
  • Investor Relations URL: N/A
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: May. 10, 2019
  • Description: Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its own pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("GNHAF","name")
  • Description: =YCI("GNHAF","description")
  • Sector: =YCI("GNHAF","sector")
  • Industry: =YCI("GNHAF","industry")
  • Est. Current Fiscal Year End: =YCI("GNHAF","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.